Skip to content

Evaluation of Mechanical Stapler for Aortic Anastomoses

Evaluation of Mechanical Stapler for Aortic Anastomoses

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00319475
Enrollment
10
Registered
2006-04-27
Start date
2006-02-28
Completion date
2006-07-31
Last updated
2006-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Aneurysm, Abdominal, Leriche Syndrome

Brief summary

Demonstrate the safety and performance of the Aortic Stapler when used to attach a synthetic graft to an aorta in AAA and Leriche Syndrome patients

Interventions

PROCEDUREAAA or AF/IB (end-to-end) in patients with Leriche Syndrome

Sponsors

SVSE 2000 Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patient age is between 21 to 85 years old. * Patient is diagnosed with Abdominal Aortic Aneurysm (AAA) or -aorto-Iliac/Femoral Occlusive Arterial Disease (Leriche' syndrome) by CT-Angio examination and/or angiography examination in patients with Leriche' syndrome. * Patient with an aneurysm at the neck of the proximal or distal site that is between 5 to 10 mm and with a diameter of 16-22 mm. * Patient is scheduled for AAA repair

Exclusion criteria

* Pregnant women * Active malignancy * Ruptured aneurysm * Thoraco-AAA * Patient with at least one of the following unstable risk factors: * Renal disease (Cr \>2) * Ischemic heart disease (unstable Angina) * Obstructive Pulmonary Disease (contraindicated for open aortic surgery by respiratory function exam) * Severe CHF (EF \< 25%) * Patient with known allergy to metals or to the contrast media * Participation in current or recent (within 60 days prior to surgery) clinical trial

Design outcomes

Primary

MeasureTime frame
Time to complete each stapled anastomosis.

Secondary

MeasureTime frame
Post-operative follow up:
no leakage
no dilatation
no fistula or hematoma at the anastomotic sites

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026